TrialLancet (London, England)2012

Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.

Christine Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.